TY - ADVS
T1 - EMN09 Study: Is Carfilzomib, Bendamustine, and Dexamethasone Effective in Treating Advanced Myeloma?
AU - Cutter, Noelle L
N1 - By: Noelle Cutter, PhD Posted: Tuesday, August 17, 2021 Despite recent advances, limited treatment options remain for patients with advanced multiple myeloma. Francesca Gay, MD, and colleagues from the University of Torino, Italy, found that combination treatment using carfilzomib, bendamustine, and dexamethasone appears to be an effective treatment in the outpatient setting for this patient population.
PY - 2021/8/17
Y1 - 2021/8/17
N2 - Despite recent advances, limited treatment options remain for patients with advanced multiple myeloma. Francesca Gay, MD, and colleagues from the University of Torino, Italy, found that combination treatment using carfilzomib, bendamustine, and dexamethasone appears to be an effective treatment in the outpatient setting for this patient population. However, they cautioned, infection prophylaxis and attention to those with cardiovascular predisposition are necessary. Their results were published in the journal Cancer.
AB - Despite recent advances, limited treatment options remain for patients with advanced multiple myeloma. Francesca Gay, MD, and colleagues from the University of Torino, Italy, found that combination treatment using carfilzomib, bendamustine, and dexamethasone appears to be an effective treatment in the outpatient setting for this patient population. However, they cautioned, infection prophylaxis and attention to those with cardiovascular predisposition are necessary. Their results were published in the journal Cancer.
UR - https://jnccn360.org/mm/medical-literature/emn09-study-is-carfilzomib-bendamustine-and-dexamethasone-effective-in-treating-advanced-myeloma/
M3 - Web publication/site
ER -